Robbert J. van Alphen
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
-
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
Papers in
- Oncology 6
- Cancer Treatment and Pharmacology 2
- Colorectal Cancer Treatments and Studies 2
- PARP inhibition in cancer therapy 2
-
- Prostate Cancer Treatment and Research 4
- Radiation Therapy and Dosimetry 1
- Co-authors
- Ron H.J. Mathijssen (13 shared papers)Peter de Bruijn (6 shared papers)Ron H. N. van Schaik (4 shared papers)Agnes Jager (5 shared papers)Jaap Verweij (2 shared papers)Esther Oomen‐de Hoop (6 shared papers)Teun van Gelder (5 shared papers)Eric Brouwer (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Clinical Pharmacokinetics (3 papers)Clinical Cancer Research (1 paper)Breast Cancer Research and Treatment (1 paper)British Journal of Clinical Pharmacology (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Robbert J. van Alphen
18 papers receiving 277 citations
Peers
Comparison fields: 5 of 57
- Pharmacology 72
- Oncology 77
- Genetics 56
- Molecular Medicine 10
- Endocrine and Autonomic Systems 12
Countries citing papers authored by Robbert J. van Alphen
This map shows the geographic impact of Robbert J. van Alphen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robbert J. van Alphen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robbert J. van Alphen more than expected).
Fields of papers citing papers by Robbert J. van Alphen
This network shows the impact of papers produced by Robbert J. van Alphen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robbert J. van Alphen. The network helps show where Robbert J. van Alphen may publish in the future.
Co-authors
The 25 scholars most cited alongside Robbert J. van Alphen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 51 | |
| 2 | 2011 | 42 | |
| 3 | 2019 | 36 | |
| 4 | 2015 | 30 | |
| 5 | 2021 | 24 | |
| 6 | 2015 | 23 | |
| 7 | 2021 | 15 | |
| 8 | 2019 | 13 | |
| 9 | 2017 | 13 | |
| 10 | 2016 | 12 | |
| 11 | 2019 | 8 | |
| 12 | 2021 | 7 | |
| 13 | 2024 | 2 | |
| 14 | 2022 | 2 | |
| 15 | 2016 | 2 | |
| 16 | 2025 | 1 | |
| 17 | 2016 | 1 | |
| 18 | 2018 | 1 |
About Robbert J. van Alphen
Robbert J. van Alphen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pharmacology, Molecular Biology and Genetics, having authored 18 papers that have together received 283 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Estrogen and related hormone effects (2 papers), Cancer Treatment and Pharmacology (2 papers), Colorectal Cancer Treatments and Studies (2 papers), PARP inhibition in cancer therapy (2 papers), Cancer Genomics and Diagnostics (1 paper) and Radiation Therapy and Dosimetry (1 paper). The work is most often cited by research in Pharmacology (72 citations), Oncology (77 citations), Genetics (56 citations), Molecular Medicine (10 citations) and Endocrine and Autonomic Systems (12 citations). Robbert J. van Alphen has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Ron H.J. Mathijssen, Peter de Bruijn, Ron H. N. van Schaik, Agnes Jager, Jaap Verweij, Esther Oomen‐de Hoop, Teun van Gelder, Eric Brouwer, Lisette Binkhorst and Laurent Vernillet. Their work appears in journals such as Journal of Clinical Oncology, Clinical Pharmacokinetics, Clinical Cancer Research, Breast Cancer Research and Treatment and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.